| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.917 | 0.003 | 0.917 | Aldehyde oxidase inhibitor | 0.913 0.003 DBMET01444 0.795 0.004 DBMET01445 | ||
| 0.796 | 0.002 | 0.796 | Estrogen receptor alpha antagonist | 0.762 0.002 DBMET01444 0.678 0.003 DBMET01445 | ||
| 0.717 | 0.022 | 0.735 | Caspase 9 stimulant | 0.735 0.02 DBMET01444 0.686 0.025 DBMET01445 | DBMET01444 | |
| 0.586 | 0.004 | 0.586 | Estrogen antagonist | 0.501 0.004 DBMET01444 0.459 0.004 DBMET01445 | ||
| 0.533 | 0.003 | 0.533 | Estrogen agonist | 0.485 0.004 DBMET01444 0.457 0.004 DBMET01445 | ||
| 0.519 | 0.024 | 0.519 | 5 Hydroxytryptamine release stimulant | 0.444 0.037 DBMET01444 0.377 0.051 DBMET01445 | ||
| 0.496 | 0.003 | 0.562 | Dopamine D1 antagonist | 0.533 0.003 DBMET01444 0.562 0.003 DBMET01445 | DBMET01445 | |
| 0.478 | 0.004 | 0.478 | Estrogen receptor beta antagonist | 0.402 0.004 DBMET01444 0.368 0.004 DBMET01445 | ||
| 0.492 | 0.029 | 0.519 | Vasodilator, peripheral | 0.519 0.024 DBMET01444 0.49 0.03 DBMET01445 | DBMET01444 | |
| 0.458 | 0.022 | 0.475 | Vasodilator, coronary | 0.475 0.019 DBMET01444 0.461 0.021 DBMET01445 | DBMET01444 | |
| 0.465 | 0.028 | 0.482 | Spasmolytic | 0.482 0.025 DBMET01444 0.479 0.026 DBMET01445 | DBMET01444 | |
| 0.446 | 0.015 | 0.446 | Sigma receptor agonist | 0.411 0.02 DBMET01444 0.412 0.02 DBMET01445 | ||
| 0.442 | 0.013 | 0.462 | Calcium channel activator | 0.422 0.017 DBMET01444 0.462 0.009 DBMET01445 | DBMET01445 | |
| 0.456 | 0.028 | 0.468 | Caspase 3 stimulant | 0.468 0.025 DBMET01444 0.431 0.035 DBMET01445 | DBMET01444 | |
| 0.427 | 0.024 | 0.473 | Hypoxia-inducible factor 1 alpha inhibitor | 0.44 0.022 DBMET01444 0.473 0.017 DBMET01445 | DBMET01445 | |
| 0.4 | 0.008 | 0.409 | NOS3 expression enhancer | 0.409 0.008 DBMET01444 0.341 0.012 DBMET01445 | DBMET01444 | |
| 0.472 | 0.083 | 0.536 | Apoptosis agonist | 0.499 0.074 DBMET01444 0.536 0.064 DBMET01445 | DBMET01445 | |
| 0.389 | 0.002 | 0.406 | Prolactin inhibitor | 0.379 0.002 DBMET01444 0.406 0.002 DBMET01445 | DBMET01445 | |
| 0.388 | 0.007 | 0.501 | Dopamine D2 antagonist | 0.434 0.006 DBMET01444 0.501 0.005 DBMET01445 | DBMET01445 | |
| 0.388 | 0.008 | 0.493 | Dopamine antagonist | 0.431 0.007 DBMET01444 0.493 0.005 DBMET01445 | DBMET01445 | |
| 0.417 | 0.046 | 0.421 | Cholesterol antagonist | 0.421 0.045 DBMET01444 0.372 0.056 DBMET01445 | DBMET01444 | |
| 0.353 | 0.009 | 0.365 | Neurotrophic factor enhancer | 0.365 0.008 DBMET01444 0.326 0.012 DBMET01445 | DBMET01444 | |
| 0.351 | 0.012 | 0.452 | Alpha adrenoreceptor antagonist | 0.384 0.01 DBMET01444 0.452 0.007 DBMET01445 | DBMET01445 | |
| 0.338 | 0.015 | 0.338 | Lipocortins synthesis antagonist | 0.338 0.015 DBMET01444 0.295 0.022 DBMET01445 | ||
| 0.328 | 0.006 | 0.457 | Alpha 2a adrenoreceptor antagonist | 0.396 0.005 DBMET01444 0.457 0.004 DBMET01445 | DBMET01445 | |
| 0.324 | 0.005 | 0.376 | Alpha 2c adrenoreceptor antagonist | 0.341 0.005 DBMET01444 0.376 0.005 DBMET01445 | DBMET01445 | |
| 0.356 | 0.036 | 0.356 | Sodium/bile acid cotransporter inhibitor | 0.343 0.045 DBMET01444 0.315 0.066 DBMET01445 | ||
| 0.322 | 0.005 | 0.637 | Dopamine agonist | 0.399 0.005 DBMET01444 0.637 0.004 DBMET01445 | DBMET01445 | |
| 0.304 | 0.008 | 0.413 | Alpha 2 adrenoreceptor antagonist | 0.359 0.006 DBMET01444 0.413 0.005 DBMET01445 | DBMET01445 | |
| 0.396 | 0.104 | 0.396 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.396 0.104 DBMET01444 0.396 0.104 DBMET01445 | ||
| 0.305 | 0.026 | 0.305 | 5 Hydroxytryptamine 1E antagonist | 0.303 0.028 DBMET01444 0.255 0.069 DBMET01445 | ||
| 0.317 | 0.039 | 0.317 | Psychostimulant | 0.309 0.04 DBMET01444 0.286 0.046 DBMET01445 | ||
| 0.325 | 0.049 | 0.369 | DNA damaging | 0.342 0.043 DBMET01444 0.369 0.035 DBMET01445 | DBMET01445 | |
| 0.294 | 0.019 | 0.38 | Topoisomerase II inhibitor | 0.29 0.019 DBMET01444 0.38 0.011 DBMET01445 | DBMET01445 | |
| 0.287 | 0.015 | 0.287 | 5 Hydroxytryptamine 2B antagonist | 0.274 0.017 DBMET01444 0.27 0.017 DBMET01445 | ||
| 0.277 | 0.008 | 0.277 | NMDA receptor antagonist | 0.212 0.013 DBMET01444 0.137 0.028 DBMET01445 | ||
| 0.344 | 0.079 | 0.396 | Transcription factor NF kappa B inhibitor | 0.357 0.075 DBMET01444 0.396 0.064 DBMET01445 | DBMET01445 | |
| 0.292 | 0.03 | 0.322 | P-glycoprotein inhibitor | 0.3 0.029 DBMET01444 0.322 0.025 DBMET01445 | DBMET01445 | |
| 0.273 | 0.013 | 0.337 | Alpha 1 adrenoreceptor antagonist | 0.287 0.012 DBMET01444 0.337 0.009 DBMET01445 | DBMET01445 | |
| 0.268 | 0.012 | 0.327 | Alpha 2b adrenoreceptor antagonist | 0.286 0.01 DBMET01444 0.327 0.008 DBMET01445 | DBMET01445 | |
| 0.305 | 0.051 | 0.333 | Transcription factor STAT3 inhibitor | 0.321 0.044 DBMET01444 0.333 0.039 DBMET01445 | DBMET01445 | |
| 0.361 | 0.109 | 0.361 | Calcium channel L-type activator | 0.292 0.164 DBMET01444 0.292 0.164 DBMET01445 | ||
| 0.351 | 0.099 | 0.374 | Histamine release inhibitor | 0.374 0.089 DBMET01444 0.238 0.165 DBMET01445 | DBMET01444 | |
| 0.253 | 0.007 | 0.253 | Sigma receptor antagonist | 0.212 0.008 DBMET01444 0.187 0.009 DBMET01445 | ||
| 0.3 | 0.056 | 0.347 | Transcription factor STAT inhibitor | 0.307 0.052 DBMET01444 0.347 0.035 DBMET01445 | DBMET01445 | |
| 0.255 | 0.017 | 0.381 | Antiadrenergic | 0.275 0.015 DBMET01444 0.381 0.009 DBMET01445 | DBMET01445 | |
| 0.258 | 0.022 | 0.258 | Antipruritic | 0.242 0.027 DBMET01444 0.205 0.046 DBMET01445 | ||
| 0.251 | 0.017 | 0.377 | Adrenaline antagonist | 0.271 0.015 DBMET01444 0.377 0.009 DBMET01445 | DBMET01445 | |
| 0.251 | 0.021 | 0.251 | Cholinergic antagonist | 0.235 0.024 DBMET01444 0.201 0.032 DBMET01445 | ||
| 0.311 | 0.081 | 0.334 | Antithrombotic | 0.321 0.076 DBMET01444 0.334 0.07 DBMET01445 | DBMET01445 | |
| 0.246 | 0.021 | 0.246 | Acetylcholine antagonist | 0.23 0.024 DBMET01444 0.197 0.031 DBMET01445 | ||
| 0.249 | 0.027 | 0.285 | Lipid peroxidase inhibitor | 0.277 0.022 DBMET01444 0.285 0.021 DBMET01445 | DBMET01445 | |
| 0.242 | 0.02 | 0.242 | 5 Hydroxytryptamine 3E antagonist | 0.242 0.02 DBMET01444 0.23 0.028 DBMET01445 | ||
| 0.229 | 0.009 | 0.229 | 5 Hydroxytryptamine uptake inhibitor | 0.22 0.01 DBMET01444 0.201 0.011 DBMET01445 | ||
| 0.224 | 0.004 | 0.224 | Estrogen receptor beta agonist | 0.184 0.005 DBMET01444 0.159 0.006 DBMET01445 | ||
| 0.245 | 0.026 | 0.245 | Acetylcholine M1 receptor antagonist | 0.243 0.027 DBMET01444 0.24 0.028 DBMET01445 | ||
| 0.231 | 0.013 | 0.283 | Alpha 1a adrenoreceptor antagonist | 0.238 0.013 DBMET01444 0.283 0.01 DBMET01445 | DBMET01445 | |
| 0.32 | 0.103 | 0.32 | Antiobesity | 0.316 0.106 DBMET01444 0.272 0.138 DBMET01445 | ||
| 0.225 | 0.012 | 0.277 | Alpha 1b adrenoreceptor antagonist | 0.226 0.012 DBMET01444 0.277 0.008 DBMET01445 | DBMET01445 | |
| 0.217 | 0.005 | 0.329 | Dopamine D5 antagonist | 0.237 0.004 DBMET01444 0.329 0.004 DBMET01445 | DBMET01445 | |
| 0.239 | 0.032 | 0.245 | Cholinergic | 0.245 0.03 DBMET01444 0.22 0.038 DBMET01445 | DBMET01444 | |
| 0.23 | 0.024 | 0.23 | 5 Hydroxytryptamine 2 antagonist | 0.218 0.026 DBMET01444 0.202 0.03 DBMET01445 | ||
| 0.252 | 0.049 | 0.252 | Anesthetic general | 0.245 0.052 DBMET01444 0.168 0.096 DBMET01445 | ||
| 0.228 | 0.025 | 0.235 | Acetylcholinesterase inhibitor | 0.235 0.024 DBMET01444 0.214 0.029 DBMET01445 | DBMET01444 | |
| 0.256 | 0.062 | 0.265 | Tyrosine 3 hydroxylase inhibitor | 0.257 0.062 DBMET01444 0.265 0.055 DBMET01445 | DBMET01445 | |
| 0.215 | 0.021 | 0.215 | Acetylcholine muscarinic antagonist | 0.203 0.024 DBMET01444 0.182 0.029 DBMET01445 | ||
| 0.213 | 0.019 | 0.217 | Antihistaminic | 0.217 0.018 DBMET01444 0.137 0.036 DBMET01445 | DBMET01444 | |
| 0.195 | 0.005 | 0.495 | Dopamine D2 agonist | 0.227 0.005 DBMET01444 0.495 0.004 DBMET01445 | DBMET01445 | |
| 0.192 | 0.005 | 0.192 | Estrogen receptor alpha agonist | 0.132 0.006 DBMET01444 0.108 0.008 DBMET01445 | ||
| 0.262 | 0.078 | 0.338 | Antioxidant | 0.3 0.062 DBMET01444 0.338 0.049 DBMET01445 | DBMET01445 | |
| 0.208 | 0.024 | 0.244 | Adenylate cyclase inhibitor | 0.244 0.02 DBMET01444 0.189 0.028 DBMET01445 | DBMET01444 | |
| 0.196 | 0.015 | 0.196 | Histamine H1 receptor antagonist | 0.194 0.015 DBMET01444 0.109 0.037 DBMET01445 | ||
| 0.198 | 0.02 | 0.198 | Histamine antagonist | 0.197 0.02 DBMET01444 0.116 0.04 DBMET01445 | ||
| 0.248 | 0.078 | 0.253 | Hypoglycemic | 0.253 0.075 DBMET01444 0.25 0.077 DBMET01445 | DBMET01444 | |
| 0.185 | 0.017 | 0.256 | Topoisomerase II alpha inhibitor | 0.175 0.019 DBMET01444 0.256 0.01 DBMET01445 | DBMET01445 | |
| 0.2 | 0.036 | 0.2 | Bone formation stimulant | 0.181 0.041 DBMET01444 0.174 0.044 DBMET01445 | ||
| 0.198 | 0.035 | 0.205 | Arachidonic acid antagonist | 0.205 0.028 DBMET01444 0.188 0.045 DBMET01445 | DBMET01444 | |
| 0.238 | 0.077 | 0.333 | Vasodilator | 0.257 0.065 DBMET01444 0.333 0.038 DBMET01445 | DBMET01445 | |
| 0.23 | 0.074 | 0.253 | Cyclic AMP phosphodiesterase inhibitor | 0.249 0.064 DBMET01444 0.253 0.062 DBMET01445 | DBMET01445 | |
| 0.159 | 0.009 | 0.159 | Dopamine uptake inhibitor | 0.148 0.01 DBMET01444 0.14 0.011 DBMET01445 | ||
| 0.177 | 0.028 | 0.186 | Adenylate cyclase stimulant | 0.186 0.021 DBMET01444 0.163 0.044 DBMET01445 | DBMET01444 | |
| 0.292 | 0.143 | 0.327 | MAP kinase kinase 6 inhibitor | 0.292 0.143 DBMET01444 0.327 0.111 DBMET01445 | DBMET01445 | |
| 0.182 | 0.032 | 0.199 | Alkylator | 0.176 0.035 DBMET01444 0.199 0.027 DBMET01445 | DBMET01445 | |
| 0.166 | 0.018 | 0.166 | 5 Hydroxytryptamine 1A antagonist | 0.153 0.02 DBMET01444 0.141 0.021 DBMET01445 | ||
| 0.15 | 0.003 | 0.159 | Dopamine D5 agonist | 0.156 0.003 DBMET01444 0.159 0.003 DBMET01445 | DBMET01445 | |
| 0.172 | 0.026 | 0.172 | Nav1.1 sodium channel blocker | 0.151 0.033 DBMET01444 0.163 0.028 DBMET01445 | ||
| 0.148 | 0.005 | 0.148 | 5 Hydroxytryptamine 2A agonist | 0.123 0.009 DBMET01444 0.105 0.013 DBMET01445 | ||
| 0.175 | 0.033 | 0.18 | Topoisomerase I inhibitor | 0.172 0.034 DBMET01444 0.18 0.032 DBMET01445 | DBMET01445 | |
| 0.23 | 0.089 | 0.249 | Superoxide dismutase inhibitor | 0.249 0.075 DBMET01444 0.19 0.129 DBMET01445 | DBMET01444 | |
| 0.207 | 0.067 | 0.214 | Insulin sensitizer | 0.214 0.06 DBMET01444 0.21 0.064 DBMET01445 | DBMET01444 | |
| 0.181 | 0.044 | 0.22 | Tubulin antagonist | 0.218 0.032 DBMET01444 0.22 0.031 DBMET01445 | DBMET01445 | |
| 0.139 | 0.005 | 0.139 | Estrogen-related receptor beta agonist | 0.124 0.008 DBMET01444 0.109 0.016 DBMET01445 | ||
| 0.17 | 0.036 | 0.175 | Cholesterol synthesis inhibitor | 0.175 0.034 DBMET01444 0.15 0.045 DBMET01445 | DBMET01444 | |
| 0.175 | 0.042 | 0.175 | Calcium channel blocker | 0.17 0.044 DBMET01444 0.155 0.054 DBMET01445 | ||
| 0.148 | 0.015 | 0.148 | Alpha 1d adrenoreceptor antagonist | 0.136 0.016 DBMET01444 0.145 0.015 DBMET01445 | ||
| 0.153 | 0.02 | 0.153 | Acetylcholine nicotinic antagonist | 0.144 0.022 DBMET01444 0.116 0.031 DBMET01445 | ||
| 0.134 | 0.003 | 0.134 | GABA uptake inhibitor | 0.134 0.003 DBMET01444 0.124 0.003 DBMET01445 | ||
| 0.147 | 0.017 | 0.147 | NMDA 2 receptor antagonist | 0.108 0.028 DBMET01444 0.066 0.055 DBMET01445 | ||
| 0.167 | 0.037 | 0.167 | Nav1.6 sodium channel blocker | 0.152 0.051 DBMET01444 0.15 0.054 DBMET01445 | ||
| 0.159 | 0.031 | 0.166 | Butyrylcholinesterase inhibitor | 0.166 0.029 DBMET01444 0.121 0.046 DBMET01445 | DBMET01444 | |
| 0.148 | 0.019 | 0.148 | Anabolic | 0.139 0.024 DBMET01444 0.13 0.031 DBMET01445 | ||
| 0.168 | 0.041 | 0.168 | Neuropeptide Y1 antagonist | 0.149 0.067 DBMET01444 | ||
| 0.135 | 0.007 | 0.135 | Estradiol 17 beta-dehydrogenase inhibitor | 0.122 0.008 DBMET01444 0.074 0.014 DBMET01445 | ||
| 0.274 | 0.147 | 0.31 | 15-Lipoxygenase inhibitor | 0.31 0.125 DBMET01444 0.302 0.131 DBMET01445 | DBMET01444 | |
| 0.196 | 0.069 | 0.231 | Nitric oxide antagonist | 0.213 0.063 DBMET01444 0.231 0.057 DBMET01445 | DBMET01445 | |
| 0.136 | 0.011 | 0.162 | Alpha 1 adrenoreceptor agonist | 0.143 0.01 DBMET01444 0.162 0.009 DBMET01445 | DBMET01445 | |
| 0.174 | 0.049 | 0.174 | Toll-Like receptor 9 antagonist | 0.169 0.051 DBMET01444 | ||
| 0.167 | 0.043 | 0.167 | 5 Hydroxytryptamine antagonist | 0.151 0.049 DBMET01444 0.132 0.058 DBMET01445 | ||
| 0.147 | 0.025 | 0.147 | Creatine kinase inhibitor | 0.147 0.025 DBMET01444 0.104 0.055 DBMET01445 | ||
| 0.148 | 0.027 | 0.148 | 5 Hydroxytryptamine 2C antagonist | 0.14 0.029 DBMET01444 0.137 0.03 DBMET01445 | ||
| 0.163 | 0.043 | 0.202 | Anesthetic local | 0.177 0.039 DBMET01444 0.202 0.032 DBMET01445 | DBMET01445 | |
| 0.138 | 0.018 | 0.173 | Alpha adrenoreceptor agonist | 0.151 0.016 DBMET01444 0.173 0.012 DBMET01445 | DBMET01445 | |
| 0.134 | 0.014 | 0.138 | Histamine H2 receptor antagonist | 0.131 0.015 DBMET01444 0.138 0.013 DBMET01445 | DBMET01445 | |
| 0.124 | 0.005 | 0.149 | Dopamine D3 agonist | 0.125 0.005 DBMET01444 0.149 0.004 DBMET01445 | DBMET01445 | |
| 0.131 | 0.013 | 0.131 | Nicotinic alpha4beta2 receptor antagonist | 0.13 0.013 DBMET01444 0.103 0.029 DBMET01445 | ||
| 0.146 | 0.029 | 0.146 | 5 Hydroxytryptamine 2A antagonist | 0.135 0.032 DBMET01444 0.123 0.037 DBMET01445 | ||
| 0.257 | 0.142 | 0.285 | Immunosuppressant | 0.264 0.138 DBMET01444 0.285 0.125 DBMET01445 | DBMET01445 | |
| 0.166 | 0.053 | 0.193 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.167 0.053 DBMET01444 0.193 0.043 DBMET01445 | DBMET01445 | |
| 0.197 | 0.086 | 0.255 | Antimitotic | 0.236 0.065 DBMET01444 0.255 0.058 DBMET01445 | DBMET01445 | |
| 0.205 | 0.094 | 0.31 | Free radical scavenger | 0.257 0.065 DBMET01444 0.31 0.049 DBMET01445 | DBMET01445 | |
| 0.129 | 0.02 | 0.17 | Dopamine D4 antagonist | 0.135 0.019 DBMET01444 0.17 0.015 DBMET01445 | DBMET01445 | |
| 0.121 | 0.014 | 0.121 | Adrenaline uptake inhibitor | 0.118 0.014 DBMET01444 0.096 0.02 DBMET01445 | ||
| 0.11 | 0.004 | 0.11 | Alpha 1L adrenoreceptor antagonist | 0.11 0.004 DBMET01444 0.1 0.004 DBMET01445 | ||
| 0.118 | 0.013 | 0.118 | Acetylcholine M5 receptor antagonist | 0.115 0.014 DBMET01444 0.074 0.028 DBMET01445 | ||
| 0.127 | 0.022 | 0.131 | Adrenaline agonist | 0.125 0.023 DBMET01444 0.131 0.021 DBMET01445 | DBMET01445 | |
| 0.131 | 0.027 | 0.131 | 5 Hydroxytryptamine 1 antagonist | 0.12 0.03 DBMET01444 0.111 0.033 DBMET01445 | ||
| 0.106 | 0.004 | 0.106 | Dopamine autoreceptor agonist | 0.068 0.005 DBMET01444 0.055 0.006 DBMET01445 | ||
| 0.119 | 0.018 | 0.139 | Beta tubulin antagonist | 0.139 0.014 DBMET01444 0.117 0.018 DBMET01445 | DBMET01444 | |
| 0.121 | 0.02 | 0.147 | Dopamine D3 antagonist | 0.125 0.019 DBMET01444 0.147 0.015 DBMET01445 | DBMET01445 | |
| 0.104 | 0.005 | 0.104 | Leukotriene A4 hydrolase inhibitor | 0.1 0.005 DBMET01444 0.097 0.006 DBMET01445 | ||
| 0.267 | 0.168 | 0.267 | Analgesic | 0.221 0.212 DBMET01444 | ||
| 0.12 | 0.022 | 0.12 | Keratolytic | 0.118 0.022 DBMET01444 0.09 0.037 DBMET01445 | ||
| 0.121 | 0.023 | 0.121 | Opioid kappa receptor antagonist | 0.099 0.036 DBMET01444 0.077 0.063 DBMET01445 | ||
| 0.107 | 0.01 | 0.107 | Dopamine transporter inhibitor | 0.106 0.01 DBMET01444 0.104 0.011 DBMET01445 | ||
| 0.104 | 0.009 | 0.104 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.081 0.016 DBMET01444 0.052 0.04 DBMET01445 | ||
| 0.15 | 0.057 | 0.15 | Nav1.2 sodium channel blocker | 0.128 0.074 DBMET01444 0.121 0.082 DBMET01445 | ||
| 0.112 | 0.02 | 0.112 | Neuronal nicotinic receptor antagonist | 0.104 0.023 DBMET01444 0.088 0.03 DBMET01445 | ||
| 0.106 | 0.014 | 0.117 | 5 Hydroxytryptamine 5A antagonist | 0.102 0.015 DBMET01444 0.117 0.012 DBMET01445 | DBMET01445 | |
| 0.146 | 0.057 | 0.146 | Farnesoid X receptor antagonist | 0.139 0.067 DBMET01444 0.122 0.099 DBMET01445 | ||
| 0.144 | 0.06 | 0.162 | Toll-Like receptor antagonist | 0.162 0.048 DBMET01444 0.142 0.061 DBMET01445 | DBMET01444 | |
| 0.104 | 0.02 | 0.104 | Acetylcholine M2 receptor antagonist | 0.082 0.028 DBMET01444 0.059 0.046 DBMET01445 | ||
| 0.171 | 0.088 | 0.206 | Hepatoprotectant | 0.183 0.077 DBMET01444 0.206 0.061 DBMET01445 | DBMET01445 | |
| 0.139 | 0.056 | 0.139 | Nav1.3 sodium channel blocker | 0.123 0.07 DBMET01444 0.123 0.07 DBMET01445 | ||
| 0.156 | 0.073 | 0.161 | Diuretic | 0.161 0.068 DBMET01444 | DBMET01444 | |
| 0.106 | 0.024 | 0.106 | 5 Hydroxytryptamine 7 antagonist | 0.097 0.026 DBMET01444 0.08 0.031 DBMET01445 | ||
| 0.104 | 0.023 | 0.106 | Calcium channel L-type blocker | 0.106 0.022 DBMET01444 0.088 0.032 DBMET01445 | DBMET01444 | |
| 0.12 | 0.04 | 0.189 | HIV-1 integrase (Overall Integration) inhibitor | 0.157 0.023 DBMET01444 0.189 0.014 DBMET01445 | DBMET01445 | |
| 0.173 | 0.093 | 0.222 | Amyloid beta aggregation inhibitor | 0.222 0.067 DBMET01444 0.191 0.083 DBMET01445 | DBMET01444 | |
| 0.086 | 0.006 | 0.088 | Alpha 1b adrenoreceptor agonist | 0.088 0.006 DBMET01444 0.083 0.007 DBMET01445 | DBMET01444 | |
| 0.114 | 0.034 | 0.114 | Histamine N-methyltransferase inhibitor | 0.096 0.05 DBMET01444 0.076 0.071 DBMET01445 | ||
| 0.122 | 0.046 | 0.124 | Multidrug resistance-associated protein 1 inhibitor | 0.124 0.044 DBMET01444 0.114 0.056 DBMET01445 | DBMET01444 | |
| 0.11 | 0.035 | 0.116 | Phosphodiesterase 6D inhibitor | 0.116 0.029 DBMET01444 0.104 0.045 DBMET01445 | DBMET01444 | |
| 0.085 | 0.01 | 0.091 | Lysine-specific demethylase 1A inhibitor | 0.091 0.009 DBMET01444 0.061 0.026 DBMET01445 | DBMET01444 | |
| 0.152 | 0.079 | 0.152 | Melanin inhibitor | 0.151 0.08 DBMET01444 0.134 0.107 DBMET01445 | ||
| 0.135 | 0.064 | 0.149 | Toll-Like receptor 2 antagonist | 0.143 0.058 DBMET01444 0.149 0.053 DBMET01445 | DBMET01445 | |
| 0.095 | 0.023 | 0.095 | Acetylcholine M5 receptor agonist | 0.095 0.023 DBMET01444 0.074 0.04 DBMET01445 | ||
| 0.076 | 0.005 | 0.076 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.067 0.007 DBMET01444 0.041 0.015 DBMET01445 | ||
| 0.266 | 0.195 | 0.295 | Cyclophilin D inhibitor | 0.286 0.175 DBMET01444 0.295 0.167 DBMET01445 | DBMET01445 | |
| 0.087 | 0.017 | 0.113 | Alpha tubulin antagonist | 0.113 0.013 DBMET01444 0.086 0.018 DBMET01445 | DBMET01444 | |
| 0.208 | 0.138 | 0.208 | Gastrin inhibitor | 0.199 0.151 DBMET01444 | ||
| 0.124 | 0.055 | 0.196 | DNA intercalator | 0.122 0.056 DBMET01444 0.196 0.027 DBMET01445 | DBMET01445 | |
| 0.089 | 0.02 | 0.089 | Androgen agonist | 0.076 0.026 DBMET01444 0.073 0.028 DBMET01445 | ||
| 0.075 | 0.006 | 0.075 | Sigma 2 receptor antagonist | 0.058 0.008 DBMET01444 0.042 0.012 DBMET01445 | ||
| 0.14 | 0.072 | 0.143 | Ca2+-transporting ATPase inhibitor | 0.14 0.072 DBMET01444 0.143 0.063 DBMET01445 | DBMET01445 | |
| 0.14 | 0.073 | 0.141 | Pregnane X receptor agonist | 0.141 0.072 DBMET01444 | DBMET01444 | |
| 0.086 | 0.018 | 0.098 | 5 Hydroxytryptamine 5 antagonist | 0.082 0.02 DBMET01444 0.098 0.016 DBMET01445 | DBMET01445 | |
| 0.109 | 0.042 | 0.109 | Opioid antagonist | 0.085 0.063 DBMET01444 | ||
| 0.079 | 0.013 | 0.079 | Nicotinic alpha3beta2 receptor antagonist | 0.079 0.013 DBMET01444 0.06 0.026 DBMET01445 | ||
| 0.068 | 0.003 | 0.068 | NMDA receptor phencyclidine site antagonist | 0.048 0.003 DBMET01444 0.036 0.004 DBMET01445 | ||
| 0.114 | 0.05 | 0.114 | Toll-Like receptor 4 antagonist | 0.11 0.056 DBMET01444 0.099 0.072 DBMET01445 | ||
| 0.078 | 0.016 | 0.078 | Calcium channel P-type blocker | 0.078 0.016 DBMET01444 0.068 0.032 DBMET01445 | ||
| 0.067 | 0.005 | 0.067 | Delayed rectifier potassium channel blocker | 0.061 0.007 DBMET01444 0.04 0.021 DBMET01445 | ||
| 0.076 | 0.014 | 0.081 | Prolactin release inhibitor | 0.076 0.014 DBMET01444 0.081 0.01 DBMET01445 | DBMET01445 | |
| 0.067 | 0.005 | 0.067 | Estrone sulfatase inhibitor | 0.062 0.006 DBMET01444 0.051 0.007 DBMET01445 | ||
| 0.084 | 0.023 | 0.084 | NMDA 2C receptor antagonist | 0.065 0.039 DBMET01444 | ||
| 0.141 | 0.082 | 0.141 | MAP kinase kinase 4 inhibitor | |||
| 0.189 | 0.13 | 0.235 | Cardiotonic | 0.206 0.113 DBMET01444 0.235 0.092 DBMET01445 | DBMET01445 | |
| 0.091 | 0.035 | 0.091 | CC chemokine 5 receptor agonist | 0.081 0.062 DBMET01444 | ||
| 0.102 | 0.047 | 0.102 | Calcium antagonist | 0.102 0.047 DBMET01444 0.098 0.049 DBMET01445 | ||
| 0.102 | 0.051 | 0.102 | Interleukin 12 antagonist | 0.088 0.078 DBMET01444 | ||
| 0.073 | 0.023 | 0.073 | Potassium channel intermediate-conductance Ca-activated blocker | 0.073 0.023 DBMET01444 | ||
| 0.213 | 0.163 | 0.239 | Apoptosis antagonist | 0.238 0.14 DBMET01444 0.239 0.139 DBMET01445 | DBMET01445 | |
| 0.088 | 0.039 | 0.088 | Analgesic, opioid | 0.072 0.059 DBMET01444 | ||
| 0.071 | 0.024 | 0.071 | NMDA 2A receptor antagonist | 0.05 0.038 DBMET01444 | ||
| 0.067 | 0.021 | 0.067 | 5 Hydroxytryptamine 2 agonist | 0.062 0.025 DBMET01444 0.05 0.039 DBMET01445 | ||
| 0.064 | 0.018 | 0.064 | Nicotinic receptor alpha3 subunit antagonist | 0.055 0.022 DBMET01444 0.045 0.029 DBMET01445 | ||
| 0.144 | 0.099 | 0.162 | Interleukin 6 antagonist | 0.151 0.087 DBMET01444 0.162 0.072 DBMET01445 | DBMET01445 | |
| 0.049 | 0.005 | 0.049 | Estrogen-related receptor beta antagonist | 0.04 0.011 DBMET01444 0.034 0.02 DBMET01445 | ||
| 0.061 | 0.017 | 0.061 | Adenylate cyclase 1 inhibitor | 0.054 0.022 DBMET01444 | ||
| 0.082 | 0.039 | 0.082 | Opioid mu receptor antagonist | |||
| 0.097 | 0.055 | 0.097 | Bile acid receptor antagonist | 0.096 0.059 DBMET01444 | ||
| 0.137 | 0.097 | 0.14 | Interferon gamma antagonist | 0.137 0.097 DBMET01444 0.14 0.093 DBMET01445 | DBMET01445 | |
| 0.067 | 0.027 | 0.067 | NMDA 2B receptor antagonist | 0.051 0.042 DBMET01444 | ||
| 0.073 | 0.035 | 0.08 | Beta adrenoreceptor antagonist | 0.075 0.032 DBMET01444 0.08 0.027 DBMET01445 | DBMET01445 | |
| 0.077 | 0.039 | 0.077 | Phospholipase D inhibitor | 0.072 0.048 DBMET01444 0.068 0.059 DBMET01445 | ||
| 0.091 | 0.054 | 0.091 | Androgen antagonist | 0.085 0.06 DBMET01444 0.078 0.068 DBMET01445 | ||
| 0.07 | 0.033 | 0.071 | Beta 3 adrenoreceptor antagonist | 0.071 0.032 DBMET01444 0.067 0.04 DBMET01445 | DBMET01444 | |
| 0.084 | 0.047 | 0.084 | Macrophage migration inhibitory factor inhibitor | 0.081 0.05 DBMET01444 | ||
| 0.07 | 0.034 | 0.07 | Aromatase inhibitor | 0.064 0.039 DBMET01444 0.069 0.035 DBMET01445 | ||
| 0.067 | 0.034 | 0.067 | Acetylcholine M3 receptor antagonist | 0.057 0.045 DBMET01444 | ||
| 0.067 | 0.034 | 0.069 | Phosphodiesterase 1C inhibitor | 0.068 0.032 DBMET01444 0.069 0.031 DBMET01445 | DBMET01445 | |
| 0.037 | 0.006 | 0.119 | Dopamine D1 agonist | 0.05 0.005 DBMET01444 0.119 0.003 DBMET01445 | DBMET01445 | |
| 0.054 | 0.022 | 0.054 | NMDA receptor subunit 3B antagonist | 0.039 0.036 DBMET01444 | ||
| 0.104 | 0.073 | 0.11 | Cystathionine beta-synthase inhibitor | 0.105 0.072 DBMET01444 0.11 0.066 DBMET01445 | DBMET01445 | |
| 0.111 | 0.08 | 0.111 | MAO inhibitor | 0.106 0.084 DBMET01444 0.105 0.085 DBMET01445 | ||
| 0.066 | 0.035 | 0.066 | Phosphodiesterase 1B inhibitor | 0.063 0.039 DBMET01444 | ||
| 0.146 | 0.115 | 0.146 | Phospholipase C inhibitor | 0.145 0.117 DBMET01444 | ||
| 0.054 | 0.024 | 0.054 | Histamine H3 receptor antagonist | 0.052 0.025 DBMET01444 | ||
| 0.158 | 0.129 | 0.158 | Hypolipemic | 0.152 0.134 DBMET01444 0.149 0.137 DBMET01445 | ||
| 0.079 | 0.05 | 0.079 | MAP kinase kinase 7 inhibitor | |||
| 0.092 | 0.065 | 0.092 | Toll-Like receptor 3 antagonist | 0.092 0.065 DBMET01444 | ||
| 0.144 | 0.118 | 0.144 | Neurotensin receptor agonist | |||
| 0.044 | 0.019 | 0.044 | 5 Hydroxytryptamine 2B agonist | 0.04 0.024 DBMET01444 | ||
| 0.126 | 0.102 | 0.126 | MAP3K9 inhibitor | |||
| 0.053 | 0.029 | 0.058 | Squalene epoxidase inhibitor | 0.058 0.022 DBMET01444 0.058 0.023 DBMET01445 | DBMET01445 | |
| 0.099 | 0.077 | 0.107 | DOPA decarboxylase inhibitor | 0.102 0.073 DBMET01444 0.107 0.063 DBMET01445 | DBMET01445 | |
| 0.052 | 0.03 | 0.052 | Nicotinic receptor alpha4 subunit antagonist | 0.05 0.032 DBMET01444 0.049 0.035 DBMET01445 | ||
| 0.127 | 0.106 | 0.127 | Phospholipase A2 inhibitor | 0.125 0.108 DBMET01444 | ||
| 0.072 | 0.051 | 0.072 | Glycine receptor agonist | 0.072 0.051 DBMET01444 0.066 0.064 DBMET01445 | ||
| 0.056 | 0.036 | 0.061 | Sphingosine kinase 2 inhibitor | 0.061 0.031 DBMET01444 0.055 0.038 DBMET01445 | DBMET01444 | |
| 0.035 | 0.015 | 0.035 | Sigma 1 receptor antagonist | 0.029 0.017 DBMET01444 0.029 0.018 DBMET01445 | ||
| 0.065 | 0.045 | 0.065 | 5 Hydroxytryptamine 1B antagonist | 0.059 0.052 DBMET01444 | ||
| 0.092 | 0.073 | 0.092 | Bronchodilator | 0.092 0.073 DBMET01444 | ||
| 0.082 | 0.063 | 0.086 | Antineoplastic alkaloid | 0.086 0.059 DBMET01444 | DBMET01444 | |
| 0.03 | 0.011 | 0.041 | Alpha 1a adrenoreceptor agonist | 0.032 0.01 DBMET01444 0.041 0.007 DBMET01445 | DBMET01445 | |
| 0.046 | 0.027 | 0.046 | Opioid kappa receptor agonist | |||
| 0.042 | 0.024 | 0.042 | NMDA receptor subunit 3A antagonist | |||
| 0.076 | 0.058 | 0.076 | Interferon agonist | 0.075 0.061 DBMET01444 | ||
| 0.058 | 0.041 | 0.058 | Lipocortins synthesis agonist | 0.058 0.039 DBMET01444 | ||
| 0.112 | 0.097 | 0.119 | Interleukin 4 antagonist | 0.119 0.087 DBMET01444 | DBMET01444 | |
| 0.051 | 0.036 | 0.054 | 5 Hydroxytryptamine 4 antagonist | 0.05 0.038 DBMET01444 0.054 0.03 DBMET01445 | DBMET01445 | |
| 0.061 | 0.046 | 0.061 | Beta 2 adrenoreceptor agonist | 0.061 0.046 DBMET01444 0.061 0.047 DBMET01445 | ||
| 0.06 | 0.046 | 0.067 | Heme oxygenase stimulant | 0.06 0.046 DBMET01444 0.067 0.029 DBMET01445 | DBMET01445 | |
| 0.113 | 0.1 | 0.114 | Protein kinase stimulant | 0.114 0.099 DBMET01444 | DBMET01444 | |
| 0.049 | 0.036 | 0.082 | Dopamine D4 agonist | 0.053 0.032 DBMET01444 0.082 0.019 DBMET01445 | DBMET01445 | |
| 0.051 | 0.039 | 0.051 | Opioid agonist | |||
| 0.033 | 0.022 | 0.037 | Glucocorticoid antagonist | 0.037 0.02 DBMET01444 | DBMET01444 | |
| 0.069 | 0.059 | 0.069 | Acetylcholine M4 receptor antagonist | 0.065 0.064 DBMET01444 | ||
| 0.042 | 0.034 | 0.042 | Heme oxygenase inhibitor | 0.042 0.034 DBMET01444 | ||
| 0.044 | 0.037 | 0.044 | Glycine transporter inhibitor | |||
| 0.101 | 0.095 | 0.129 | Amylase inhibitor | 0.104 0.093 DBMET01444 0.129 0.075 DBMET01445 | DBMET01445 | |
| 0.035 | 0.029 | 0.035 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.035 0.029 DBMET01444 | ||
| 0.022 | 0.016 | 0.022 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.063 | 0.058 | 0.063 | Glutamate (mGluR7) antagonist | |||
| 0.034 | 0.029 | 0.034 | 5-Alpha-reductase inhibitor | 0.033 0.03 DBMET01444 | ||
| 0.04 | 0.036 | 0.04 | 5 Hydroxytryptamine 2C agonist | 0.039 0.038 DBMET01444 | ||
| 0.161 | 0.157 | 0.19 | Interleukin agonist | 0.19 0.13 DBMET01444 | DBMET01444 | |
| 0.036 | 0.031 | 0.039 | Alpha 1d adrenoreceptor agonist | 0.039 0.027 DBMET01444 | DBMET01444 | |
| 0.055 | 0.05 | 0.055 | Opioid delta receptor antagonist | |||
| 0.091 | 0.088 | 0.091 | 5 Hydroxytryptamine 3A agonist | |||
| 0.031 | 0.028 | 0.031 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.098 | 0.095 | 0.105 | Microtubule formation inhibitor | 0.105 0.082 DBMET01444 0.103 0.086 DBMET01445 | DBMET01444 | |
| 0.05 | 0.047 | 0.065 | Beta 1 adrenoreceptor antagonist | 0.052 0.044 DBMET01444 0.065 0.031 DBMET01445 | DBMET01445 | |
| 0.097 | 0.095 | 0.097 | Acetylcholine release stimulant | |||
| 0.102 | 0.101 | 0.102 | Transcription factor STAT6 inhibitor | |||
| 0.091 | 0.091 | 0.13 | Chelator | 0.108 0.067 DBMET01444 0.13 0.046 DBMET01445 | DBMET01445 | |
| 0.204 | 0.203 | 0.204 | GABA C receptor rho-3 antagonist | |||
| 0.08 | 0.08 | 0.081 | MAO A inhibitor | 0.081 0.08 DBMET01445 | DBMET01445 | |
| 0.169 | 0.17 | 0.171 | DNA synthesis inhibitor | 0.171 0.167 DBMET01445 | DBMET01445 | |
| 0.19 | 0.196 | 0.213 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.213 0.131 DBMET01445 | DBMET01445 | |
| 0.042 | 0.049 | 0.05 | Beta 2 adrenoreceptor antagonist | 0.05 0.036 DBMET01445 | DBMET01445 | |
| 0.12 | 0.126 | 0.129 | Sphingosine 1-phosphate receptor 5 antagonist | 0.129 0.102 DBMET01444 | DBMET01444 | |
| 0.051 | 0.061 | 0.056 | Heat shock protein 90 beta antagonist | 0.056 0.047 DBMET01445 | DBMET01445 | |
| 0.05 | 0.061 | 0.057 | Sphingosine kinase inhibitor | 0.054 0.052 DBMET01444 0.057 0.046 DBMET01445 | DBMET01445 | |
| 0.04 | 0.055 | 0.045 | Topoisomerase II beta inhibitor | 0.045 0.043 DBMET01445 | DBMET01445 | |
| 0.142 | 0.158 | 0.161 | Antiamyloidogenic | 0.161 0.133 DBMET01444 0.161 0.132 DBMET01445 | DBMET01445 | |
| 0.167 | 0.186 | 0.193 | 12-Lipoxygenase inhibitor | 0.188 0.165 DBMET01444 0.193 0.16 DBMET01445 | DBMET01445 | |
| 0.106 | 0.129 | 0.115 | Vanilloid 1 agonist | 0.115 0.101 DBMET01444 | DBMET01444 | |
| 0.045 | 0.07 | 0.058 | Alpha 2 adrenoreceptor agonist | 0.058 0.046 DBMET01445 | DBMET01445 | |
| 0.133 | 0.164 | 0.208 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.163 0.128 DBMET01444 0.208 0.095 DBMET01445 | DBMET01445 | |
| 0.096 | 0.147 | 0.114 | DNA repair enzyme inhibitor | 0.114 0.085 DBMET01445 | DBMET01445 | |
| 0.165 | 0.24 | 0.189 | 5 Hydroxytryptamine uptake stimulant | 0.189 0.175 DBMET01444 | DBMET01444 | |
| 0.103 | 0.186 | 0.146 | DNA methylase inhibitor | 0.146 0.121 DBMET01445 | DBMET01445 | |
| 0.023 | 0.141 | 0.065 | HIV-1 integrase (Strand Transfer) inhibitor | 0.065 0.038 DBMET01445 | DBMET01445 | |
| 0.029 | 0.149 | 0.067 | HIV-1 integrase (3'-Processing) inhibitor | 0.067 0.041 DBMET01445 | DBMET01445 | |
| 0.122 | 0.244 | 0.176 | Lipoxygenase inhibitor | 0.176 0.168 DBMET01445 | DBMET01445 | |
| 0.047 | 0.174 | 0.141 | M18 aspartyl aminopeptidase inhibitor | 0.102 0.089 DBMET01444 0.141 0.056 DBMET01445 | DBMET01445 | |
| 0.056 | 0.191 | 0.076 | Thioredoxin reductase inhibitor | 0.076 0.074 DBMET01445 | DBMET01445 | |
| 0.124 | 0.276 | 0.173 | RNA-directed DNA polymerase inhibitor | 0.173 0.147 DBMET01445 | DBMET01445 | |
| 0.034 | 0.208 | 0.074 | HIV-1 integrase inhibitor | 0.074 0.043 DBMET01445 | DBMET01445 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |